Dalian BIO-CHEM Company Limited

SHSE:603360 Voorraadrapport

Marktkapitalisatie: CN¥9.7b

Dalian BIO-CHEM Inkomsten in het verleden

Verleden criteriumcontroles 2/6

Dalian BIO-CHEM has been growing earnings at an average annual rate of 5.7%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 8.3% per year. Dalian BIO-CHEM's return on equity is 17.7%, and it has net margins of 27%.

Belangrijke informatie

5.7%

Groei van de winst

6.7%

Groei van de winst per aandeel

Chemicals Groei van de industrie12.1%
Inkomstengroei8.3%
Rendement op eigen vermogen17.7%
Nettomarge27.0%
Laatste winstupdate30 Sep 2024

Recente prestatie-updates uit het verleden

Recent updates

Shareholders Are Optimistic That Dalian BIO-CHEM (SHSE:603360) Will Multiply In Value

Oct 29
Shareholders Are Optimistic That Dalian BIO-CHEM (SHSE:603360) Will Multiply In Value

Market Might Still Lack Some Conviction On Dalian BIO-CHEM Company Limited (SHSE:603360) Even After 29% Share Price Boost

Oct 01
Market Might Still Lack Some Conviction On Dalian BIO-CHEM Company Limited (SHSE:603360) Even After 29% Share Price Boost

Here's Why Dalian BIO-CHEM (SHSE:603360) Can Manage Its Debt Responsibly

Sep 26
Here's Why Dalian BIO-CHEM (SHSE:603360) Can Manage Its Debt Responsibly

These 4 Measures Indicate That Dalian BIO-CHEM (SHSE:603360) Is Using Debt Reasonably Well

Jun 12
These 4 Measures Indicate That Dalian BIO-CHEM (SHSE:603360) Is Using Debt Reasonably Well

Returns on Capital Paint A Bright Future For Dalian BIO-CHEM (SHSE:603360)

Apr 23
Returns on Capital Paint A Bright Future For Dalian BIO-CHEM (SHSE:603360)

Dalian BIO-CHEM Company Limited (SHSE:603360) Surges 41% Yet Its Low P/E Is No Reason For Excitement

Apr 01
Dalian BIO-CHEM Company Limited (SHSE:603360) Surges 41% Yet Its Low P/E Is No Reason For Excitement

Here's Why Dalian BIO-CHEM (SHSE:603360) Can Manage Its Debt Responsibly

Mar 08
Here's Why Dalian BIO-CHEM (SHSE:603360) Can Manage Its Debt Responsibly

Opbrengsten en kosten

Hoe Dalian BIO-CHEM geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

SHSE:603360 Opbrengsten, kosten en inkomsten (CNY Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Sep 241,11030012646
30 Jun 241,07630311842
31 Mar 241,14635412041
31 Dec 231,06632811939
30 Sep 231,10434911235
30 Jun 231,16936514134
31 Mar 231,22037712340
31 Dec 221,25740313347
30 Sep 221,31842611557
30 Jun 221,19235512057
31 Mar 221,08229711149
31 Dec 211,0062509640
30 Sep 218752038534
30 Jun 218272177933
31 Mar 2176818411133
31 Dec 2075022210829
30 Sep 2083725115431
30 Jun 2092032215031
31 Mar 2093436512128
31 Dec 1987230711628
30 Sep 197272718026
30 Jun 196261957724
31 Mar 195391506919
31 Dec 185281456119
30 Sep 185171275225
30 Jun 184711095018
31 Mar 184401005317
31 Dec 174101005515
30 Sep 17392107710
30 Jun 17393109700
31 Mar 17402107700
31 Dec 1638998670
30 Sep 1636582650
31 Dec 1532857550
31 Dec 1434764510
31 Dec 1329149500

Kwaliteitswinsten: 603360 has high quality earnings.

Groeiende winstmarge: 603360's current net profit margins (27%) are lower than last year (31.7%).

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: 603360's earnings have grown by 5.7% per year over the past 5 years.

Versnelling van de groei: 603360's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Winst versus industrie: 603360 had negative earnings growth (-14.3%) over the past year, making it difficult to compare to the Chemicals industry average (-3.8%).

Rendement op eigen vermogen

Hoge ROE: 603360's Return on Equity (17.7%) is considered low.

Rendement op activa

Rendement op geïnvesteerd vermogen

Ontdek sterk presterende bedrijven uit het verleden

7D

1Y

7D

1Y

7D

1Y